Uptake and toxicity of copper oxide nanoparticles in cultured primary brain astrocytes

Nanotoxicology

Volumn 8, Issue 7, 2014, Pages 775-785

  Bulcke, Felix ^a   Thiel, Karsten ^b   Dringen, Ralf ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b FRAUNHOFER INSTITUTE FOR MANUFACTURING TECHNOLOGY AND ADVANCED MATERIALS IFAM   (Germany)

Author keywords

CuO NPs; Glia; ROS; Tetrathiomolybdate

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COPPER OXIDE; COPPER OXIDE NANOPARTICLE; LACTATE DEHYDROGENASE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SUCCIMER; TETRATHIOMOLYBDIC ACID; UNCLASSIFIED DRUG; CHELATING AGENT; COPPER; CUPRIC OXIDE; MOLYBDENUM;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER METABOLISM; CYTOTOXICITY; DISPERSION; EXPOSURE; HYDRODYNAMICS; INTERNALIZATION; LIGHT SCATTERING; MEMBRANE PERMEABILITY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TEMPERATURE DEPENDENCE; TRANSMISSION ELECTRON MICROSCOPY; X RAY ANALYSIS; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; METABOLISM; RAT; WISTAR RAT;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CHELATING AGENTS; COPPER; METAL NANOPARTICLES; MOLYBDENUM; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84899130975     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.829591     Document Type: Article

References (70)

1. Ahamed M, Siddiqui MA, Akhtar MJ, Ahmad I, Pant AB, Alhadlaq HA. 2010. Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Biophys Res Commun 396:578-583.
2. Ahmad Z, Vargas-Reus MA, Bakhshi R, Ryan F, Ren GG, Oktar F, et al. 2012. Antimicrobial properties of electrically formed elastomeric polyurethane-copper oxide nanocomposites for medical and dental applications. Methods Enzymol 509:87-99.
3. Allen NJ, Barres BA. 2009. Neuroscience: glia - more than just brain glue. Nature 457:675-677.
4. An L, Liu S, Yang Z, Zhang T. 2012. Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol Lett 213:220-227.
5. Balkhyour MA, Goknil MK. 2010. Total fume and metal concentrations during welding in selected factories in Jeddah, Saudi Arabia. Int J Environ Res Public Health 7:2978-2987.
6. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. 2010. Time evolution of the nanoparticle corona proteins. ACS Nano 4:3623-3632.
7. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, et al. 2006. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163:109-120.
8. Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, et al. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 118:1699-1706.
9. Cohen D, Soroka Y, Ma?or Z, Oron M, Portugal-Cohen M, Bregegere FM, et al. 2013. Evaluation of topically applied copper (II) oxide nanoparticle cytotoxicity in human skin organ culture. Toxicol In Vitro 27:292-298.
10. Cronholm P, Karlsson HL, Hedberg J, Lowe TA, Winnberg L, Elihn K, et al. 2013. Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small 9:970-982.
11. Double K. 2012. Neuronal vulnerability in Parkinson-s disease. Parkinsonism Relat Disord 18(Suppl 1):S52-S54.
12. Dringen R, Kussmaul L, Hamprecht B. 1998. Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Res Brain Res Protoc 2:223-228.
13. Dringen R, Scheiber IF, Mercer JF. 2013. Copper metabolism of astrocytes. Front Aging Neurosci 5:9.
14. Emmend?rffer A, Hecht M, Lohmann-Matthes M-L, Roesler J. 1990. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 131:269-275.
15. Fahmy B, Cormier SA. 2009. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro 23:1365-1371.
16. Fauconnier N, Pons JN, Roger J, Bee A. 1997. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J Colloid Interface Sci 194:427-433.
17. Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G. 2003. Copper- induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim Biophys Acta 1635:48-54.
18. Geppert M, Hohnholt MC, Nurnberger S, Dringen R. 2012. Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832-3839.
19. Geppert M, Hohnholt MC, Thiel K, Nurnberger S, Grunwald I, Rezwan K, et al. 2011. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101.
20. Geppert M, Petters C, Thiel K, Dringen R. 2013. The presence of serum alters the properties of iron oxide nanoparticles and lowers their accumulation by cultured brain astrocytes. J Nanopart Res 15:1349-1364.
21. Gutterer JM, Dringen R, Hirrlinger J, Hamprecht B. 1999. Purification of glutathione reductase from bovine brain, generation of an antiserum, and immunocytochemical localization of the enzyme in neural cells. J Neurochem 73:1422-1430.
22. Hamprecht B, L?ffler F. 1985. Primary glial cultures as a model for studying hormone action. Methods Enzymol 109:341-345.
23. Han X, Gelein R, Corson N, Wade-Mercer P, Jiang J, Biswas P, et al. 2011. Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 287:99-104.
24. Hanagata N, Zhuang F, Connolly S, Li J, Ogawa N, Xu M. 2011. Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis. ACS Nano 5:9326-9338.
25. Hirrlinger J, Dringen R. 2010. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63:177-188.
26. Hohnholt MC, Geppert M, Dringen R. 2011. Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater 7:3946-3954.
27. Hohnholt MC, Geppert M, Luther EM, Petters C, Bulcke F, Dringen R. 2013. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 38:227-239.
28. Hung YH, Bush AI, La Fontaine S. 2013. Links between copper and cholesterol in Alzheimer-s disease. Front Physiol 4:111.
29. Karlsson HL, Cronholm P, Gustafsson J, Moller L. 2008. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726-1732.
30. Kim JS, Adamcakova-Dodd A, O?Shaughnessy PT, Grassian VH, Thorne PS. 2011. Effects of copper nanoparticle exposure on host defense in a murine pulmonary infection model. Part Fibre Toxicol 8:29.
31. Kobayashi Y, Maeda T, Watanabe K, Ihara K, Yasuda Y, Morita T. 2011. Preparation of CuO nanoparticles by metal salt-base reaction in aqueous solution and their metallic bonding property. J Nanopart Res 13:5365-5372.
32. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, et al. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65:1513-1530.
33. Krotkiewska B, Banas T. 1992. Interaction of Zn2+ and Cu2+ ions with glyceraldehyde-3-phosphate dehydrogenase from bovine heart and rabbit muscle. Int J Biochem 24:1501-1505.
34. Ku G, Zhou M, Song S, Huang Q, Hazle J, Li C. 2012. Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano 6:7489-7496.
35. Lai JC, Blass JP. 1984. Neurotoxic effects of copper: inhibition of glycolysis and glycolytic enzymes. Neurochem Res 9:1699-1710.
36. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. 2012. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845-5857.
37. Liao M, Liu H. 2012. Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Environ Toxicol Pharmacol 34:67-80.
38. Liu Z, Liu S, Ren G, Zhang T, Yang Z. 2011. Nano-CuO inhibited voltage-gated sodium current of hippocampal CA1 neurons via reactive oxygen species but independent from G-proteins pathway. J Appl Toxicol 31:439-445.
39. Lockman PR, Koziara JM, Mumper RJ, Allen DD. 2004. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12:635-641.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
41. Luther EM, Koehler Y, Diendorf J, Epple M, Dringen R. 2011. Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 22:375101.
42. Luther EM, Schmidt MM, Diendorf J, Epple M, Dringen R. 2012. Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles. Neurochem Res 37:1639-1648.
43. Lynch I, Salvati A, Dawson KA. 2009. Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4:546-547.
44. Magaye R, Zhao J, Bowman L, Ding M. 2012. Genotoxicity and carcinogenicity of cobalt-, nickel- and copper-based nanoparticles. Exp Ther Med 4:551-561.
45. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. 2010. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 58:1094-1103.
46. McQuaid A, Mason J. 1991. A comparison of the effects of Penicillamine, Trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson?s disease therapy. J Inorg Biochem 41:87-92.
47. Midander K, Cronholm P, Karlsson HL, Elihn K, M?ller L, Leygraf C, et al. 2009. Surface characteristics, copper release, and toxicity of nano- and micrometer-sized copper and copper(II) oxide particles: a cross-disciplinary study. Small 5:389-399.
48. Oberd?rster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445.
49. Pan D, Cai X, Yalaz C, Senpan A, Omanakuttan K, Wickline SA, et al. 2012. Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles. ACS Nano 6:1260-1267.
50. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, et al. 2012. Glial cells in (patho)physiology. J Neurochem 121:4-27.
51. Rubilar O, Rai M, Tortella G, Diez MC, Seabra AB, Duran N. 2013. Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications. Biotechnol Lett 35:1365-1375.
52. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF. 2011. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32:9353-9363.
53. Scheiber IF, Dringen R. 2011a. Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocyte. Neurosci Lett 498:42-46.
54. Scheiber IF, Dringen R. 2011b. Copper accelerates glycolytic flux in cultured astrocytes. Neurochem Res 36:894-903.
55. Scheiber IF, Dringen R. 2013. Astrocyte functions in the copper homeostasis of the brain. Neurochem Int 62:556-565.
56. Scheiber IF, Dringen R, Mercer JFB. 2014. Copper: effects of deficiency and overload. In: Sigel A, Sigel H, Sigel RKO, editors. Interrelations between essential metal ions and human diseases. Vol. 13 of Metal Ions in Life Sciences. Dordrecht, NL: Springer; in press.
57. Scheiber IF, Mercer JF, Dringen R. 2010a. Copper accumulation by cultured astrocytes. Neurochem Int 56:451-460.
58. Scheiber IF, Schmidt MM, Dringen R. 2010b. Zinc prevents the copper-induced damage of cultured astrocytes. Neurochem Int 57:314-322.
59. Scheiber IF, Schmidt MM, Dringen R. 2012. Copper export by cultured astrocytes. Neurochem Int 60:292-300.
60. Szymczak W, Menzel N, Kecka L. 2007. Emission of ultrafine copper particles by universal motors controlled by phase angle modulation. J Aerosol Sci 38:520-531.
61. Takahashi S, Abe T, Gotoh J, Fukuuchi Y. 2002. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int 40:441-448.
62. Tiffany-Castiglioni E, Hong S, Qian Y. 2011. Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29:811-818.
63. Valois CR, Braz JM, Nunes ES, Vinolo MA, Lima EC, Curi R, et al. 2010. The effect of DMSA-functionalized magnetic nanoparticles on transendothelial migration of monocytes in the murine lung via a beta2 integrin-dependent pathway. Biomaterials 31:366-374.
64. Wang Z, Li N, Zhao J, White JC, Qu P, Xing B. 2012. CuO nanoparticle interaction with human epithelial cells: cellular uptake, location, export, and genotoxicity. Chem Res Toxicol 25:1512-1521.
65. Xu J, Li Z, Xu P, Xiao L, Yang Z. 2012. Nanosized copper oxide induces apoptosis through oxidative stress in podocytes. Arch Toxicol 87:1067-1073.
66. Xu L-J, Zhao J-X, Zhang T, Ren G-G, Yang Z. 2009. In vitro study on influence of nano particles of CuO on CA1 pyramidal neurons of rat hippocampus potassium currents. Environ Toxicol 24:211-217.
67. Xu M, Fujita D, Kajiwara S, Minowa T, Li X, Takemura T, et al. 2010. Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials 31:8022-8031.
68. Yeh CJ, Hsi BL, Faulk WP. 1981. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J Immunol Methods 43:269-275.
69. Yim YS, Choi JS, Kim GT, Kim CH, Shin TH, Kim DG, et al. 2012. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB). Chem Commun (Camb) 48:61-63.
70. Yu M, Mo Y, Wan R, Chien S, Zhang X, Zhang Q. 2010. Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles. Toxicol Lett 195:82-89.